MENU
+Compare
CLYYF
Stock ticker: OTC
AS OF
May 30 closing price
Price
$0.50
Change
-$0.15 (-23.08%)
Capitalization
16.94M

CLYYF Celyad Oncology SA Forecast, Technical & Fundamental Analysis

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more

CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLYYF with price predictions
Jun 27, 2025

CLYYF's RSI Oscillator stays in oversold zone for 19 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 13, 2025. You may want to consider a long position or call options on CLYYF as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLYYF just turned positive on June 20, 2025. Looking at past instances where CLYYF's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

CLYYF moved below its 50-day moving average on May 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CLYYF crossed bearishly below the 50-day moving average on May 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for CLYYF entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLYYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.391) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). CLYYF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (400.000) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLYYF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Rue Edouard Belin 2
Phone
+32 10394100
Employees
39
Web
https://www.celyad.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRZBY31.920.07
+0.23%
Commerzbank AG
CPNBQ0.06N/A
N/A
Telefonica Del Peru Sa
SJMHF0.34N/A
N/A
SJM Holdings Ltd.
KICK8.75N/A
N/A
HPN Holdings, Inc.
SALM0.87-0.07
-7.44%
Salem Media Group, Inc.

CLYYF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYYF
1D Price
Change %
CLYYF100%
N/A
ELVAF - CLYYF
47%
Loosely correlated
N/A
WHWK - CLYYF
37%
Loosely correlated
+1.58%
HLVX - CLYYF
26%
Poorly correlated
+1.03%
REPL - CLYYF
25%
Poorly correlated
N/A
WXXWY - CLYYF
25%
Poorly correlated
N/A
More